scholarly journals P-207 FLOT in clinical practice: Retrospective analysis of an oncological center

2021 ◽  
Vol 32 ◽  
pp. S170
Author(s):  
R. Fontes ◽  
J. Rodrigues ◽  
C. Oliveira ◽  
M. Peixoto ◽  
E. Couto ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Retrospective Analysis ◽  
Oncological Center

Informed consent in interventional radiology – are we doing enough?

2021 ◽  
pp. 20201368
Author(s):  
Akash Prashar ◽  
Saqib Butt ◽  
Davide Giuseppe Castiglione ◽  
Nadeem Shaida
Keyword(s):  
Interventional Radiology ◽  
Clinical Practice ◽  
Informed Consent ◽  
Blood Transfusion ◽  
Retrospective Analysis ◽  
Patient Information ◽  
Potential Risk ◽  
Current Model ◽  
Consent Form ◽  
Consent Process

Objectives: Obtaining informed consent is a mandatory part of modern clinical practice. The aim of this study was to identify how often complications relating to Interventional Radiology (IR) procedures were discussed with the patient prior to the procedure. Methods: A retrospective analysis of 100 patients who experienced a complication related to an IR procedure was performed. The patient’s procedure consent form was examined to identify whether the complication they experienced had been discussed as a possible risk. Other parts of the consent form relating to need for blood transfusion and the need for further procedures were also examined. Results: 39% of patients who experienced a complication did not have the complication documented as a potential risk on the consent form. 14% of patients required a blood transfusion but were not consented for this. 42% of patients required a further procedure or operation but were not warned of this. Conclusion: The model of gaining informed consent on the day of procedure is no longer valid. Better education and the use of clinics, patient information sheets and other resources is essential. Advances in knowledge: The paper highlights the inadequacies of the current model in gaining consent for IR procedures. A more comprehensive consent process making use of all available resources is essential.

scholarly journals Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis

2018 ◽  
Vol 37 (7) ◽  
pp. 1879-1884 ◽  
Author(s):  
M. Gamala ◽  
S. P. Linn-Rasker ◽  
M. Nix ◽  
B. G. F. Heggelman ◽  
J. M. van Laar ◽  
...  
Keyword(s):  
Decision Making ◽  
Clinical Practice ◽  
Ct Scan ◽  
Retrospective Analysis ◽  
Gouty Arthritis ◽  
Dual Energy ◽  
Dual Energy Ct

The Utility of Virtual Bronchoscopy Using a Computed Tomography Workstation for Conducting Conventional Bronchoscopy: A Retrospective Analysis of Clinical Practice

Respiration ◽  
2018 ◽  
Vol 97 (1) ◽  
pp. 52-59 ◽  
Author(s):  
Shion Miyoshi ◽  
Kazutoshi Isobe ◽  
Hiroshige Shimizu ◽  
Motoko Sunakawa ◽  
Aika Suzuki ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Clinical Practice ◽  
Retrospective Analysis ◽  
Virtual Bronchoscopy

PS-052 Retrospective analysis of bevacizumab plus irinotecan in recurrent gliobastoma multiforme in clinical practice

2016 ◽  
Vol 23 (Suppl 1) ◽  
pp. A236.2-A236
Author(s):  
A Garcia ◽  
A Rodriguez ◽  
G Durán ◽  
E López ◽  
M Touris ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Retrospective Analysis

scholarly journals Doctors recognized by the British honours systems: A retrospective analysis of the last decade

2011 ◽  
Vol 104 (12) ◽  
pp. 521-524 ◽  
Author(s):  
Shofiq Islam ◽  
Jennifer L Cole ◽  
Christopher J Taylor
Keyword(s):  
Public Health ◽  
General Practice ◽  
Clinical Practice ◽  
Retrospective Analysis ◽  
Medical Profession ◽  
Statistical Tests ◽  
Medical Community ◽  
Public Health Medicine ◽  
Significant Difference ◽  
The World

Objectives The British honours system is one of the oldest in the world rewarding individuals, including those of the medical profession. The authors were interested to see if any particular specialty was honoured to a greater extent. We aimed to establish the number of those honoured, the duration of clinical practice involved, as well as additional factors. Design A retrospective analysis of doctors receiving honours (Knight/Dame, CBE, OBE, MBE) in the last decade was performed. Setting UK-registered doctors. Participants Doctors were identified from publicly available listings. Main outcome measures Demographics of all honoured doctors, including number of years of service, specialty affiliation and the number of recipients holding professorial status were collected. Clinicians were stratified into four subgroups: General Practitioners, Physicians, Surgeons and Others. Data were analysed using parametric statistical tests. Results Four hundred and seventeen doctors were identified. Four hundred and two clinicians had a documented subspecialty affiliation. Of the 402: GPs ( n = 142), Physicians ( n = 100), Surgeons ( n = 34) and Others ( n = 126). The number of years in clinical practice from registration to conference of honours was significantly shorter for GPs when compared to hospital-based specialties ( P < 0.05). The top 10 specialties of individuals honoured are tabulated. Professors constituted 30% ( n = 131) of those honoured. These individuals were sub-divided according to specialty affiliation with a significant difference observed ( P < 0.05). Conclusions The most honoured specialty was General Practice. However, when corrected for total subspecialty population, the number one ranking specialty was Public Health Medicine. Academic clinicians are well represented. The findings may be of interest to the medical community.

A retrospective analysis of nonmetastatic primary mucosal melanoma of the vagina: Clinical practice evaluation in different French institutes.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e15500-e15500
Author(s):  
C. Vaysse ◽  
P. Pautier ◽  
T. Filleron ◽  
V. Maisongrosse ◽  
V. Lavoué ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Retrospective Analysis ◽  
Mucosal Melanoma

Retrospective analysis of sorafenib as first or second target therapy in mRCC patients in Italian centers: An update.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e15524-e15524
Author(s):  
Lisa Derosa ◽  
Angela Gernone ◽  
Franco Morelli ◽  
Teodoro Sava ◽  
Fable Zustovich ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Retrospective Analysis ◽  
Target Therapy ◽  
Performance Status ◽  
Single Agent ◽  
Progression Free Survival ◽  
Complete Response ◽  
Daily Clinical Practice ◽  
Duration Of Treatment ◽  
Ecog Performance Status

e15524 Background: With several agents available for the treatment of metastatic renal cell carcinoma (mRCC) a better understanding of their use in daily clinical practice is fundamental in the decision-making process. Methods: The REtrospective analysis of Sorafenib (So) as 1st or 2nd targET therapy (RESET) in mRCC was a retrospective, observational field study that assessed the use and safety of So in clinical practice in Italian centers. Treatments were determined by physicians per local prescribing guidelines. Patients (pts) treated with So single agent as 1st or 2nd target therapy (TT) for mRCC between 1st Jan 2008 and 31st Dec 2010 were eligible for inclusion. Endpoints included safety, overall survival (OS), progression-free survival, response rate and treatment duration. Subgroup analyses included age, ECOG performance status, prior therapy, number of metastases and line of TT with So. Results: From Feb to Jul 2012, 358 pts from 37 Italian centers were enrolled. The most common ≥ grade 3 drug-related adverse events were hand-foot skin reaction (6.7%), rash (2.2%), hypertension, fatigue and diarrhea (1.7% each). In the overall population, median OS was 17.2 months (mos) (95% CI 15.4 – 19.6 mos) and median PFS was 5.9 mos (95% CI 4.9-6.7 mos). Median duration of treatment with So was 5.03 mos. Disease control (complete response + partial response + stable disease) was observed in 198(56%) pts. In pts receiving So as first or as second TT median OS was 19.9 mos (95% CI 15.9-25.3 mos) and 16.3 mos (95% CI 13.0-18.2 mos) respectively. In the subgroup of pts treated with So 1st TT followed by sunitinib (Su) 2nd TT (44 pts) and Su 1st TT followed by So 2nd TT (173 pts), median OS was 30.4 mos (95% CI 22.0-34.8 mos) and 16.6 mos (95% CI 13.1-18.2 mos) respectively. There were 269(76%) pts that received a total of 2 lines of therapy for mRCC, 133(38%) pts 3 lines and 43(12%) pts 4 lines of therapy. Conclusions: The efficacy and safety profile of So in the setting of Italian community-based daily clinical practice was similar to data reported in prospective clinical trials. The efficacy of So was observed in both the subgroups of pts receiving So as either the first or second TT for mRCC, with intriguing OS data in first line.

Sign in / Sign up

Export Citation Format

Share Document